Artelo Biosciences, Inc.
ARTL
$5.98
-$0.21-3.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.43M | -2.96M | -4.17M | -3.12M | -3.22M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 21.00K | 87.00K | 71.00K | 83.00K | 54.00K |
| Total Other Non-Cash Items | 537.00K | 556.00K | 1.67M | 366.00K | 159.00K |
| Change in Net Operating Assets | -3.16M | 1.12M | -488.00K | -827.00K | 2.49M |
| Cash from Operations | -5.03M | -1.19M | -2.91M | -3.50M | -514.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 188.00K | -250.00K | -- |
| Cash from Investing | -- | -- | 188.00K | -250.00K | -- |
| Total Debt Issued | 0.00 | 593.00K | -129.00K | 0.00 | 737.00K |
| Total Debt Repaid | -1.24M | -- | -24.00K | -- | -- |
| Issuance of Common Stock | 178.00K | 10.27M | 1.76M | 3.44M | 1.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.06M | 10.86M | 1.61M | 3.44M | 1.82M |
| Foreign Exchange rate Adjustments | 22.00K | 4.00K | -4.00K | -42.00K | 18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.08M | 9.67M | -1.12M | -346.00K | 1.32M |